Trademark: 88532843
Status Date
Tuesday, December 7, 2021
Registration Number
6578739
Registration Date
Tuesday, December 7, 2021
Filing Date
Wednesday, July 24, 2019
Published for Opposition
Tuesday, August 24, 2021
5 Pharmaceutical and veterinary preparations for cancer and immuno-oncology; biological and biochemical preparations for the treatment of cancer in form of antibodies, antibody derivatives, binding proteins and peptides for medical or veterinary purposes; biological and biochemical preparations in form of bifunctional or multifunctional proteins with binding affinity to immune cells, in particular with binding affinity to T cells and natural killer (NK) cells, in particular for the subsequent targeting of cancer cells; biological and biochemical preparations for diagnostic use for medical or veterinary purposes, in particular in form of antibodies, antibody derivatives, binding proteins and peptides; biological and biochemical preparations for the treatment of cancer in form of antibodies, antibody derivatives, binding proteins and peptides for use within the framework of experimental and medical or veterinary assays; biological and biochemical diagnostic preparations for medical or veterinary use in form of antibodies, antibody derivatives, binding proteins and peptides for use within the framework of medical or veterinary assays
1 Biological and biochemical preparations, in particular in form of antibodies, antibody derivatives, binding proteins and peptides for laboratory and experimentation purposes, in particular for conducting experimental assays, other than for medical or veterinary purposes; biological and biochemical diagnostic preparations other than for medical or veterinary purposes, in particular in form of antibodies, antibody derivatives, binding proteins and peptides
42 Scientific and technological services, namely, research and design in the field of immuno-therapy, in particular in the field of immuno-oncology; scientific and technological services, namely, research and design in the field of virology; scientific and technological services, namely, research and design in the field of antiinfectives; scientific and technological services, namely, research and design in the field of neurodegenerative diseases; scientific and technological services, namely, research and design in the field of autoimmune diseases; in particular all of the aforesaid services related to the use of antibodies, antibody derivatives, binding proteins and peptides; scientific and technological services, namely, research and design in the field of immunotherapy by means of activating or modulating innate and adaptive immunity, in particular in the field of immune-oncology
Oct 6, 2023
Teas Change Of Correspondence Received
Oct 6, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 6, 2023
Teas Change Of Owner Address Received
Dec 7, 2021
Registered-Principal Register
Nov 3, 2021
Extension Of Time To Oppose Process - Terminated
Sep 23, 2021
Extension Of Time To Oppose Received
Aug 24, 2021
Official Gazette Publication Confirmation E-Mailed
Aug 24, 2021
Published For Opposition
Aug 4, 2021
Notification Of Notice Of Publication E-Mailed
Jul 21, 2021
Approved For Pub - Principal Register
Jul 20, 2021
Teas/Email Correspondence Entered
Jul 20, 2021
Correspondence Received In Law Office
Jul 20, 2021
Teas Response To Suspension Inquiry Received
May 29, 2021
Notification Of Letter Of Suspension E-Mailed
May 29, 2021
Letter Of Suspension E-Mailed
May 29, 2021
Suspension Letter Written
May 29, 2021
Teas/Email Correspondence Entered
May 29, 2021
Correspondence Received In Law Office
May 28, 2021
Assigned To Lie
Mar 2, 2021
Teas Response To Suspension Inquiry Received
Sep 7, 2020
Notification Of Inquiry As To Suspension E-Mailed
Sep 7, 2020
Inquiry To Suspension E-Mailed
Sep 7, 2020
Suspension Inquiry Written
Mar 7, 2020
Notification Of Letter Of Suspension E-Mailed
Mar 7, 2020
Letter Of Suspension E-Mailed
Mar 7, 2020
Suspension Letter Written
Mar 6, 2020
Teas/Email Correspondence Entered
Mar 5, 2020
Correspondence Received In Law Office
Mar 5, 2020
Teas Response To Office Action Received
Oct 22, 2019
Notification Of Priority Action E-Mailed
Oct 22, 2019
Priority Action E-Mailed
Oct 22, 2019
Priority Action Written
Oct 15, 2019
Assigned To Examiner
Aug 1, 2019
New Application Office Supplied Data Entered
Jul 29, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
